GGrantIndex
Sort

261,768 grants matching gene therapy

The Role of Wnt Genes in Vertebrate Development and Cancer

$1,730,437
Terence Yamaguchi · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Complex Neurodegenerative Disorders Clinic

$1,730,200
Justin Kwan · National Institute Of Neurological Disorders And Stroke · ZID · FY2025 · NS

Biological Characterization of Genetic Mechanisms in Neuropsychiatric Disorders

$1,730,165
Daniel Weinberger · National Institute Of Mental Health · ZIA · FY2011 · MH

TAS::75 0849::TAS R&D-OTHER SCIENCES-B RES

$1,730,100
Patrick M McDonough · Vala Sciences, Inc. · N43 · FY2011 · CA

Molecular Genetics Support to Identify Gene/Environment Interactions in Disease

$1,730,046
Kevin Gerrish · National Institute Of Environmental Health Sciences · ZIC · FY2024 · ES

Soft Tissue Sarcoma Program Project

$1,729,965
Samuel Singer · Sloan-Kettering Inst Can Research · P01 · FY2008 · CA

Systems Analysis of Epigenomic Architecture in Cancer Progression

$1,729,895
Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2019 · CA

Pre-clinical Translational Research Facility

$1,729,889
Mark Gilbert · Division Of Basic Sciences - Nci · ZIC · FY2017 · CA

Center for Lupus Research

$1,729,826
Maria Virginia Pascual · Baylor Research Institute · P50 · FY2016 · AR

Clinical Vector for TCR Immunotherapy Targeted to Melanoma

$1,729,819
Boro Dropulic · Lentigen Corporation · R44 · FY2012 · CA

Leveraging DNA damage repair pathways as therapeutic targets in womens cancers

$1,729,738
Jung-Min Lee · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Elafin Therapy for Pulmonary Arterial Hypertension

$1,729,729
Marlene Rabinovitch · Stanford University · P01 · FY2021 · HL

Elafin Therapy for Pulmonary Arterial Hypertension

$1,729,729
Marlene Rabinovitch · Stanford University · P01 · FY2020 · HL

The LIMIting AAA with meTformin (LIMIT) Trial

$1,729,290
Ronald L Dalman · Stanford University · R33 · FY2022 · HL

RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteins

$1,729,091
Benjamin F Cravatt · Ut Southwestern Medical Center · U19 · FY2023 · AI

Study of hereditary prostate cancer and human artificial chromosomes

$1,728,952
Vladimir Larionov · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Diagnosis and Risk factors of hippocampal sclerosis of aging and limbic predominant age related TDP-43 encephalopathy; common Alzheimer’s mimics

$1,728,882
Seyed Ahmad Sajjadi · University Of California-Irvine · R01 · FY2025 · AG

Predictive Personalized Public Health (P3H): A Novel Paradigm to Treat Infectious Disease

$1,728,465
Steven J. Schiff · Yale University · R01 · FY2022 · AI

Washington University Institute of Clinical and Translational Sciences (KL2)

$1,728,410
Kenneth S Polonsky · Washington University · KL2 · FY2009 · RR

Elafin Therapy for Pulmonary Arterial Hypertension

$1,728,355
Marlene Rabinovitch · Stanford University · P01 · FY2019 · HL

Pro-inflammatory cytokine lowering anti-inflammatory drugs

$1,728,312
Nigel H. Greig · National Institute On Aging · ZIA · FY2018 · AG

Discovery of genes required for expression or activity of fusion oncogenes

$1,728,242
Natasha Caplen · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

The LIMIting AAA with meTformin (LIMIT) Trial

$1,728,178
Ronald L Dalman · Stanford University · R33 · FY2023 · HL

Molecular And Pharmacological Studies Of Dopamine Receptors

$1,728,156
David Sibley · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS

Michigan Prostate SPORE

$1,727,892
Arul M Chinnaiyan · University Of Michigan At Ann Arbor · P50 · FY2022 · CA